ALNYLAM PHARMACEUTICALS, INC.
Proposal 1a.
Election of Class III Director of Alnylam to serve for a term ending in 2028: Carolyn R. Bertozzi, Ph.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1b.
Election of Class III Director of Alnylam to serve for a term ending in 2028: Margaret A. Hamburg, M.D.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1c.
Election of Class III Director of Alnylam to serve for a term ending in 2028: Colleen F. Reitan
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 1d.
Election of Class III Director of Alnylam to serve for a term ending in 2028: Amy W. Schulman
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 2.
To approve an Amendment to our Restated Certificate of Incorporation allowing for officer exculpation.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 3.
To approve the second amended and restated 2018 Stock Incentive Plan.
Caisse vote:
Against
Applicable policy or principle:
PDV_01
Proposal 4.
To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.
Caisse vote:
For
Applicable policy or principle:
PDV_01
Proposal 5.
To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2025.
Caisse vote:
For
Applicable policy or principle:
PDV_01